Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2368650C Viral treatment
09/13/2005CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them
09/13/2005CA2323863C Methods and compositions for treating and preventing mucositis
09/13/2005CA2322805C Fat emulsions for inhalational administration
09/13/2005CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
09/13/2005CA2314896C A method of preventing abuse of opioid dosage forms
09/13/2005CA2314893C Opioid agonist/antagonist combinations
09/13/2005CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/13/2005CA2248198C Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss
09/13/2005CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/13/2005CA2210022C Paroxetine hydrochloride solvates
09/13/2005CA2179634C 4-arylisoindole analgesics
09/13/2005CA2102186C Nanoparticles having a prolonged reticulo-endothelial system capture rate
09/13/2005CA2078700C Imidazolylmethyl-pyridines
09/12/2005CA2497958A1 Zeolite y alkylation catalysts
09/09/2005WO2005083430A1 Biomarkers for age-related macular degeneration (amd)
09/09/2005WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005WO2005083103A1 Method for the production of hyperbranched polysaccharide fractions
09/09/2005WO2005083086A2 Epha4 as therapeutic target of prc and pdaca
09/09/2005WO2005083083A2 Materials and methods for treatment of allergic disease
09/09/2005WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005083074A1 Tumor antigen peptides
09/09/2005WO2005083071A1 Polynucleotide participating in rheumatoid arthritis and utilization of the same
09/09/2005WO2005083070A1 Pharmaceutical composition for lowering blood sugar level
09/09/2005WO2005082977A1 Crosslinked polymers containing biomass derived materials
09/09/2005WO2005082942A2 Hydroxyethyl starch
09/09/2005WO2005082925A2 Novel steroid agonist for fxr
09/09/2005WO2005082924A1 23-hetero-analogs of ornithogalum caudatum saponin osw-1, the preparation and use thereof
09/09/2005WO2005082921A1 Method for inhibiting cellular proliferation
09/09/2005WO2005082919A1 Process for isolation and seperation of 3 biological active compounds from aloe vera leaf gel filet and the 3 compounds
09/09/2005WO2005082908A1 Pyrazolotriazines as kinase inhibitors
09/09/2005WO2005082906A1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082904A1 Preventive and/or therapeutic agent for neutrophilic inflammation disease
09/09/2005WO2005082903A1 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
09/09/2005WO2005082899A1 Oxazolidinone derivatives as antimicrobials
09/09/2005WO2005082894A1 Cell targeting conjugates
09/09/2005WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082885A1 Imidazole based kinase inhibitors
09/09/2005WO2005082884A2 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease
09/09/2005WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
09/09/2005WO2005082879A1 Coumarin derivative and use thereof
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2005082872A1 Benzothiazin-3-one compound and intermediate therefor
09/09/2005WO2005082870A1 Abc transporter inhibitor
09/09/2005WO2005082867A1 Novel 1,2,4-benzotriazine-1,4-dioxides
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082860A1 Tetracyclines and their use as calpain inhibitors
09/09/2005WO2005082858A2 Isoquinoline derivatives
09/09/2005WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082845A1 Novel therapies with somatostatin receptor agonists
09/09/2005WO2005082844A1 Treatment of diseases by using a somatostatin receptor agonist
09/09/2005WO2005082839A1 Amide compound
09/09/2005WO2005082459A2 Method of decreasing blood cells
09/09/2005WO2005082458A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis
09/09/2005WO2005082457A2 Use of substituted 1,2,3 indolizine derivatives for treating diseases associated with a pathological choroidal angiogenesis
09/09/2005WO2005082456A1 USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 FOR THE PROPHYLAXIS OF BONE DISEASES
09/09/2005WO2005082422A1 Combination of ad-p53 and chemotherapy for the treatment of tumours
09/09/2005WO2005082421A1 Use of organo-silicon compounds for constraining connective damaged tissues
09/09/2005WO2005082420A1 Stable pharmaceutical composition comprising an ace inhibitor
09/09/2005WO2005082419A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
09/09/2005WO2005082415A2 Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth
09/09/2005WO2005082414A2 Concomitant drugs of a sulfonamide and another therapeutic agent
09/09/2005WO2005082413A2 Ciclesonide and glycopyrronium combination
09/09/2005WO2005082411A1 Method of treating abnormal cell growth using c-met and-tor inhibitors
09/09/2005WO2005082397A1 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
09/09/2005WO2005082393A1 Stabilized feverfew formulations
09/09/2005WO2005082390A1 Fat accumulation inhibitors
09/09/2005WO2005082388A1 Extracts of scutellaria for the treatment of sars
09/09/2005WO2005082386A2 Manganese and iron based compounds for elastogenesis and connective tissue treatment
09/09/2005WO2005082385A1 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
09/09/2005WO2005082382A1 Formulations of thiomolybdate or thiotungstate compounds and uses thereof
09/09/2005WO2005082381A1 Administration of enoxaparin sodium to patients with severe renal impairment
09/09/2005WO2005082380A1 Heparin for the treatment of ocular pathologies
09/09/2005WO2005082379A1 Myocardial perfusion imaging using adenosine receptor agonists
09/09/2005WO2005082378A1 A medical solution, a method for producing said medical solution and use thereof
09/09/2005WO2005082377A1 INHIBITOR FOR LOWERING IN THE ACTIVITY OF ANTIHUMAN TNF-α ANTIBODY
09/09/2005WO2005082376A1 Tetracycline derivatives for the treatment of ocular pathologies
09/09/2005WO2005082375A2 Treatment of interstitial cystitis with vitamin d compounds
09/09/2005WO2005082374A1 Predictors for patients at risk for glaucoma from steroid therapy
09/09/2005WO2005082373A1 Medicinal eudistomin derivative composition
09/09/2005WO2005082372A1 COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
09/09/2005WO2005082371A2 Oral dieting composition comprising conjugated linoleic acid and caffeine
09/09/2005WO2005082370A1 Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
09/09/2005WO2005082369A1 Opioid delivery system
09/09/2005WO2005082368A1 Isoquinoline derivatives and methods of use thereof
09/09/2005WO2005082367A1 Kinase inhibitors
09/09/2005WO2005082366A1 Nk-1 receptor antagonists anesthesia recovery
09/09/2005WO2005082365A1 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders
09/09/2005WO2005082364A1 Compositions comprising hiv protease inhibitor and cytochrome p450 enzyme activity inhibitor
09/09/2005WO2005082363A1 Thiazolone compounds for treatment of cancer
1 ... 4547 4548 4549 4550 4551 4552 4553 4554 4555 4556 4557 4558 4559 4560 4561 4562 4563 4564 4565 4566 4567 ... 7860